Journal of Nuclear Medicine

Alzheimer's disease & dementia

Novel PET imaging agent detects earliest signs of Alzheimer's disease

A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B (MAO-B) in cognitively unimpaired individuals with high beta amyloid (Ab)—one of the earliest signs of Alzheimer's disease—according ...

Arthritis & Rheumatism

Ultra-low dose total body PET/CT effective for evaluating arthritis

Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of the Journal of Nuclear Medicine. ...

Diabetes

Active brown adipose tissue protects against 'pre-prediabetes'

In a prospective study of young, lean adults, PET/CT imaging revealed that higher levels of active brown adipose tissue (also known as "brown fat") are more prevalent in individuals who exhibit very early indications of metabolic ...

Neuroscience

Molecular imaging uncovers effects of COVID-19 on the brain

A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by the Journal of Nuclear Medicine. The ...

page 6 from 24